Sonic Healthcare Future Growth
Future criteria checks 1/6
Sonic Healthcare is forecast to grow earnings and revenue by 11% and 4.7% per annum respectively. EPS is expected to grow by 10.4% per annum. Return on equity is forecast to be 8.5% in 3 years.
Key information
11.0%
Earnings growth rate
10.4%
EPS growth rate
Healthcare earnings growth | 26.6% |
Revenue growth rate | 4.7% |
Future return on equity | 8.5% |
Analyst coverage | Good |
Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 93% Above Its Share Price
Jul 27These 4 Measures Indicate That Sonic Healthcare (ASX:SHL) Is Using Debt Reasonably Well
Jun 24Sonic Healthcare Limited (ASX:SHL) Investors Are Less Pessimistic Than Expected
May 08Sonic Healthcare's (ASX:SHL) Returns On Capital Not Reflecting Well On The Business
Apr 24Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 90% Above Its Share Price
Mar 07Returns On Capital At Sonic Healthcare (ASX:SHL) Have Hit The Brakes
Dec 26Is Sonic Healthcare Limited (ASX:SHL) Trading At A 46% Discount?
Dec 08Here's Why Sonic Healthcare (ASX:SHL) Can Manage Its Debt Responsibly
Nov 23It's Unlikely That The CEO Of Sonic Healthcare Limited (ASX:SHL) Will See A Huge Pay Rise This Year
Nov 09Returns At Sonic Healthcare (ASX:SHL) Appear To Be Weighed Down
Sep 19Sonic Healthcare (ASX:SHL) Will Pay A Larger Dividend Than Last Year At A$0.62
Sep 02Sonic Healthcare (ASX:SHL) Has Announced That It Will Be Increasing Its Dividend To A$0.62
Aug 19Is Sonic Healthcare Limited (ASX:SHL) Trading At A 31% Discount?
Aug 10Returns Are Gaining Momentum At Sonic Healthcare (ASX:SHL)
May 24Is Sonic Healthcare Limited (ASX:SHL) Trading At A 28% Discount?
May 11We Think Sonic Healthcare (ASX:SHL) Can Stay On Top Of Its Debt
Apr 28Sonic Healthcare's (ASX:SHL) Upcoming Dividend Will Be Larger Than Last Year's
Mar 03We Like Sonic Healthcare's (ASX:SHL) Returns And Here's How They're Trending
Feb 17Are Investors Undervaluing Sonic Healthcare Limited (ASX:SHL) By 22%?
Feb 04Here's Why We Think Sonic Healthcare (ASX:SHL) Is Well Worth Watching
Dec 04Here's Why Shareholders May Consider Paying Sonic Healthcare Limited's (ASX:SHL) CEO A Little More
Nov 10Investors Should Be Encouraged By Sonic Healthcare's (ASX:SHL) Returns On Capital
Nov 08Is There An Opportunity With Sonic Healthcare Limited's (ASX:SHL) 36% Undervaluation?
Oct 26Is Sonic Healthcare (ASX:SHL) Using Too Much Debt?
Sep 21Sonic Healthcare (ASX:SHL) Will Pay A Larger Dividend Than Last Year At A$0.60
Aug 26Does Sonic Healthcare (ASX:SHL) Deserve A Spot On Your Watchlist?
Aug 24We Like Sonic Healthcare's (ASX:SHL) Returns And Here's How They're Trending
Aug 07Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 62% Above Its Share Price
Jun 26Does Sonic Healthcare (ASX:SHL) Deserve A Spot On Your Watchlist?
May 10Shareholders Would Enjoy A Repeat Of Sonic Healthcare's (ASX:SHL) Recent Growth In Returns
Apr 28A Look At The Fair Value Of Sonic Healthcare Limited (ASX:SHL)
Mar 19Sonic Healthcare's (ASX:SHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 23Investors Should Be Encouraged By Sonic Healthcare's (ASX:SHL) Returns On Capital
Jan 22Is Sonic Healthcare (ASX:SHL) Using Too Much Debt?
Dec 26A Look At The Intrinsic Value Of Sonic Healthcare Limited (ASX:SHL)
Dec 14We Like Sonic Healthcare's (ASX:SHL) Returns And Here's How They're Trending
Oct 23With EPS Growth And More, Sonic Healthcare (ASX:SHL) Is Interesting
Oct 12Does Sonic Healthcare (ASX:SHL) Have A Healthy Balance Sheet?
Sep 15Is Sonic Healthcare Limited (ASX:SHL) Worth AU$42.5 Based On Its Intrinsic Value?
Aug 26Does Sonic Healthcare (ASX:SHL) Deserve A Spot On Your Watchlist?
Jul 12Sonic Healthcare (ASX:SHL) Seems To Use Debt Rather Sparingly
Jun 11Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 10,395 | 691 | 1,133 | 1,551 | 12 |
6/30/2026 | 9,942 | 621 | 1,014 | 1,492 | 14 |
6/30/2025 | 9,516 | 525 | 929 | 1,382 | 14 |
6/30/2024 | 8,967 | 511 | 492 | 1,072 | N/A |
3/31/2024 | 8,680 | 508 | 531 | 1,105 | N/A |
12/31/2023 | 8,392 | 505 | 571 | 1,138 | N/A |
9/30/2023 | 8,281 | 595 | 772 | 1,304 | N/A |
6/30/2023 | 8,169 | 685 | 974 | 1,471 | N/A |
3/31/2023 | 8,417 | 850 | 1,260 | 1,721 | N/A |
12/31/2022 | 8,666 | 1,015 | 1,545 | 1,970 | N/A |
9/30/2022 | 9,003 | 1,238 | 1,696 | 2,098 | N/A |
6/30/2022 | 9,340 | 1,461 | 1,847 | 2,226 | N/A |
3/31/2022 | 9,209 | 1,463 | 1,885 | 2,249 | N/A |
12/31/2021 | 9,078 | 1,465 | 1,922 | 2,273 | N/A |
9/30/2021 | 8,916 | 1,390 | 1,801 | 2,158 | N/A |
6/30/2021 | 8,754 | 1,315 | 1,680 | 2,043 | N/A |
3/31/2021 | 8,339 | 1,133 | 1,492 | 1,840 | N/A |
12/31/2020 | 7,923 | 951 | 1,304 | 1,637 | N/A |
9/30/2020 | 7,378 | 739 | 1,170 | 1,498 | N/A |
6/30/2020 | 6,832 | 528 | 1,036 | 1,360 | N/A |
3/31/2020 | 6,703 | 554 | 827 | 1,187 | N/A |
12/31/2019 | 6,573 | 581 | 618 | 1,013 | N/A |
9/30/2019 | 6,353 | 565 | 540 | 930 | N/A |
6/30/2019 | 6,134 | 550 | 461 | 847 | N/A |
3/31/2019 | 5,952 | 510 | 452 | 816 | N/A |
12/31/2018 | 5,770 | 470 | 443 | 784 | N/A |
9/30/2018 | 5,655 | 473 | 442 | 776 | N/A |
6/30/2018 | 5,541 | 476 | 440 | 768 | N/A |
3/31/2018 | 5,430 | 468 | N/A | 762 | N/A |
12/31/2017 | 5,319 | 460 | N/A | 755 | N/A |
9/30/2017 | 5,220 | 444 | N/A | 746 | N/A |
6/30/2017 | 5,122 | 428 | N/A | 736 | N/A |
3/31/2017 | 5,081 | 444 | N/A | 726 | N/A |
12/31/2016 | 5,040 | 460 | N/A | 716 | N/A |
9/30/2016 | 5,029 | 456 | N/A | 712 | N/A |
6/30/2016 | 5,018 | 451 | N/A | 708 | N/A |
3/31/2016 | 4,829 | 406 | N/A | 647 | N/A |
12/31/2015 | 4,639 | 362 | N/A | 585 | N/A |
9/30/2015 | 4,420 | 355 | N/A | 549 | N/A |
6/30/2015 | 4,201 | 348 | N/A | 512 | N/A |
3/31/2015 | 4,115 | 365 | N/A | 540 | N/A |
12/31/2014 | 4,029 | 382 | N/A | 568 | N/A |
9/30/2014 | 3,971 | 383 | N/A | 562 | N/A |
6/30/2014 | 3,913 | 385 | N/A | 556 | N/A |
3/31/2014 | 3,799 | 373 | N/A | 517 | N/A |
12/31/2013 | 3,685 | 362 | N/A | 477 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SHL's forecast earnings growth (11% per year) is above the savings rate (2.6%).
Earnings vs Market: SHL's earnings (11% per year) are forecast to grow slower than the Australian market (12.6% per year).
High Growth Earnings: SHL's earnings are forecast to grow, but not significantly.
Revenue vs Market: SHL's revenue (4.7% per year) is forecast to grow slower than the Australian market (5.7% per year).
High Growth Revenue: SHL's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SHL's Return on Equity is forecast to be low in 3 years time (8.5%).